ClinicalTrials.gg
Not yet recruitingNCT07816952Updated Sep 16, 2026

Young Adult Women and Wearable Posture Corrector Device

An interventional study of Wearable posture corrector device in This Study Aims to Examine the Effect of a Wearable Posture Corrector Device on Back Pain Body Image and Postural Awareness in Young Adult Women, sponsored by Pamukkale University. Not yet recruiting. Open to female participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Pamukkale University · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Pain by Pamukkale University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Pamukkale University.

Planned enrollment
2nd of 15
90 · median 52
Started
2026
with 2 others
No phase
14 of 15
3 open now
Registered
14th of 15
by date

Among the 15 studies in Pain by Pamukkale University, this one is the 2nd largest by planned enrollment, is one of 3 that started in 2026, is one of 14 with no phase, and was the 14th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

3 of the 15 studies in Pain by Pamukkale University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 25 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Pain by Pamukkale University, or all of them as a file.
02

Study summary

To improve posture, methods such as strengthening specific muscles or focusing on body alignment are commonly used. In addition to elastic posture correctors, electronic posture reminders can also be utilized. Thanks to current wearable technologies and their companion mobile apps, individuals can enhance their posture awareness. Although studies show that wearable technologies effectively foster posture awareness, the effects of wearable posture-correcting devices on back pain (VAS) and body image are not sufficiently known. This study aims to examine the effects of a wearable posture-correcting device on back pain, body image, and posture awareness to improve posture in young adult women.

Read the detailed description

This study is a randomized controlled experimental trial with pretest-posttest measurements in experimental and control groups. The study will be conducted with young adult female students. The sample size was calculated using the G*Power software, based on a similar study that utilized the same scale (VAS). In the a priori power analysis, based on an independent samples t-test with 80% power, an alpha level of 0.05, and an effect size of 0.56, a total of 82 participants-41 in the experimental group and 41 in the control group-were required. Considering potential sample dropouts, the sample size was increased by at least 10% and finalized at a total of 90 participants.Female participants who apply to join the study, express their willingness to use the wearable posture-correcting device, and meet the inclusion criteria will be randomly assigned to the experimental and control groups according to their order of application. Data will be collected using an 'Introductory Information Form', the 'VAS' to assess back pain, the 'Body Image Scale', and the 'Postural Awareness Scale'.Data analysis will be performed using the SPSS 31.0 software package. The test of significance of the difference between two means (independent samples t-test) will be utilized to reveal the differences between the two independent groups. A significance level of alpha 0.05 will be accepted.

03

Conditions studied

  • This Study Aims to Examine the Effect of a Wearable Posture Corrector Device on Back Pain Body Image and Postural Awareness in Young Adult Women

Browse trials for

Keywords

  • Wearable Electronic Devices
  • Young Adult
  • Pain
  • Body Image
  • Posture
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Who are studying at *** University
  • Women aged 18-25 years
  • Women without spinal deformities,
  • No history of spinal surgery,
  • Back pain rated as VAS ≥ 3,
  • A Postural Awareness Scale score of ≤ 46,
  • No diagnosed psychiatric disorders,
  • No dermatological conditions that would prevent the use of the device

Exclusion criteria

Exclusion Criteria:

  • Not being a student at *** University
  • Age \< 18 or > 25 years
  • Presence of spinal deformity
  • Previous spinal surgery
  • Back pain VAS score \< 3
  • Postural Awareness Scale score > 46
  • Diagnosed psychiatric illness
  • Dermatological conditions preventing device use
  • Male sex / gender
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Experimental Group

    A pretest will be administered to all participating women using the 'Introductory Information Form', the 'VAS' to evaluate back pain, the 'Body Image Scale' , and the 'Postural Awareness Scale'. Women in the experimental group will be provided with the wearable posture corrector device and instructed on how to use it. Following the completion of the intervention period, the posttest will be conducted by re-administering the 'VAS', 'Body Image Scale', and 'Postural Awareness Scale' to the experimental group.

    Device: Wearable posture corrector device

  • No intervention
    Control Group

    No intervention will be administered to the control group, and data will be collected using the same measurement instruments at the same time points.

Interventions

  • DeviceWearable posture corrector device

    The planned device is designed for general use, requires no prescription, does not serve a clinical diagnostic or therapeutic purpose, and can be used without the need to consult a healthcare professional. The device is placed on the upper back during use. When the user assumes an incorrect posture, the device emits gentle vibrations to alert them, thereby promoting posture awareness. Women in the experimental group will use the device for a total of 4 weeks.

06

What researchers measure

Primary outcomes

  1. 'Introductory Information Form'

    This form, prepared by the researchers in accordance with the literature, consists of 9 questions containing the sociodemographic data of women.

    Time frame: Baseline

  2. VAS (Back Pain)

    It is a single-item, non-invasive, universally used visual analog measurement tool designed to determine pain perception. It consists of a 100 mm horizontal line, numbered from 0 representing 'no pain' to 10 representing 'unbearable pain' at either end to indicate the severity of symptoms.

    Time frame: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks

  3. Body Image Scale

    The 'Body Image Scale' was developed by Saylan \& Soyyiğit (2022) to evaluate body image in individuals during adolescence and emerging adulthood and was reported to be a valid and reliable instrument. It is a 5-point Likert-type scale (1 = Strongly disagree to 5 = Strongly agree) consisting of 21 items. It comprises four subdimensions: negative body perception, evaluation sensitivity, positive body perception, and body modification. Five items of the scale (Items 4, 7, 15, 16, and 17) are reverse-scored, with the total score ranging from a minimum of 21 to a maximum of 105. Higher scores obtained from the scale indicate a more negative body image.

    Time frame: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks

  4. Postural Awareness Scale

    The Turkish validity and reliability of the Postural Awareness Scale was conducted by Dursun and Önen (2018). The purpose of the scale is to assess an individual's self-reported body posture awareness. It is a 7-point Likert-type scale (ranging from 1 = 'not at all true for me' to 7 = 'completely true for me') consisting of 11 items. Items 1, 2, 3, 4, 5, and 12 of the scale are reverse-scored, and the total score obtainable ranges from a minimum of 11 to a maximum of 77.

    Time frame: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 7 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2026
First posted
Sep 14, 2026
StartEst.
Oct 2026
Primary completionEst.
May 2027
CompletionEst.
Jun 2027
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07816952
Responsible party
Neslihan Nur Dursun (Principal Investigator, Pamukkale University) — Principal investigator
First posted
Sep 14, 2026
Start date
Oct 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Sep 16, 2026

Study contacts

Neslihan Nur Dursun
Contact
neslihannurdursun@gmail.com
+90 543 929 64 85

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion